HomeMarketsSharesOption Care Health Inc

Trade Option Care Health Inc - OPCH CFD

Market is not available at the momentMarket information is presented
as of 2026-09-28T19:45:49+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.07
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.022262 %
(-$0.45)

Trade size with leverage ~ $2,000.00

Money from leverage ~ $$1,000.00


-0.02226%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
0.00004 %
($0.00)

Trade size with leverage ~ $2,000.00

Money from leverage ~ $$1,000.00


0.00004%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity0.1
Margin50.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close23.06
Open22.99
1-Year Change-15.66%
Day's Range22.87 - 23.37

Trade Option Care Health Inc - OPCH

About Option Care Health Inc

Option Care Health, Inc. is an independent provider of home and alternate site infusion services. The Company provides a therapy portfolio through its network of approximately 97 full-service pharmacies and 57 stand-alone ambulatory infusion suites. Its infusion services include the clinical management of infusion therapy, nursing support and care coordination. It contracts with managed care organizations, third-party payers, hospitals, physicians and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients’ homes or other nonhospital settings. It administers a range of therapies and services, including anti-infectives infusion, heart failure, chronic inflammatory disorders, immunoglobulin infusion, bleeding disorders infusion, nutrition support infusion, neurological disorders, women’s health and others. It also offers nursing platform that include specialty nursing resources to healthcare providers.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Option Care Health Inc revenues increased 13% to $3.44B. Net income totaled $139.9M vs. loss of $8.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Total other expense decrease of 38% to $67M (expense), Other, net - Balancing value decrease of 53% to $10.8M (expense).

Equity composition

Common Stock $.0001 Par, 3/11, 125M auth., 57,063,496 issd., less 2,642,398 shs. in Treas. @ $10.6M. Insiders & strategic holders own 2.32%. IPO: 8/96, 4M shares @ $13 by PaineWebber Inc. 03/05, Co. acq. Chronimed Inc. @ 1.12 sh of BIOS (14,363,933 shs issd.) & also name changed from MIM Corporation following the merger.

Latest shares articles

Cellnex stock forecast
Cellnex stock forecast: BlackRock raises stake to 6.398%
Cellnex Telecom is a European telecom-infrastructure company listed in Madrid. In September, BlackRock raised its stake to 6.398% as Cellnex continued its share-buyback programme. Explore third-party CNLX price targets Past performance is not a reliable indicator of future results.
11 hours ago
Siemens stock forecast
Siemens stock forecast: VinSpeed high-speed rail contract
Siemens is a German industrial group with businesses across automation, infrastructure and mobility. On 22 September 2026, Siemens Mobility signed a high-speed rail contract with VinSpeed. Explore third-party SIE price targets. Past performance is not a reliable indicator of future results.
12 hours ago
DeFi Technologies stock forecast
DeFi Technologies stock forecast: Valour hedge fund launch
DeFi Technologies' subsidiary Valour launched its first hedge fund on 21 September 2026, expanding the business beyond exchange-traded products. Explore third-party DEFT price targets and technical analysis. Past performance is not a reliable indicator of future results.
14 hours ago
Buzzi Unicem logo displayed on a smartphone with a financial market chart in the background.
Buzzi stock forecast: H1 EBITDA and margin pressure
Buzzi is an Italian building-materials group listed in Milan, with recent trading shaped by a September share-price decline and a new investor presentation. Explore third-party BZU price targets and technical analysis. Past performance is not a reliable indicator of future results.
11:07, 25 September 2026

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready